NewTimeSpace (newtimespace.com) News, on August 31, 2026, the chip theme traded in a choppy session, with ASMPT (00522.HK) edging up. As of 13:47, the stock was quoted at HKD 161.100, up 0.12%.
NewTimeSpace (newtimespace.com) News, on August 31, 2026, the robotics theme fluctuated higher, while XIAOMI-W (01810.HK) weakened. As of 13:32, the stock was quoted at HKD 27.660, down 0.58%.
NewTimeSpace News: August 31, 2026, BLACK SESAME(02533.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 458.47 million, increased by 81.3% YoY.
NewTimeSpace News: On 31 August 2026, ABBISKO-B (02256.HK) announced that the first patient has been dosed in the Phase I trial of ABSK211, an oral small-molecule pan-KRAS inhibitor developed by its subsidiary Abbisko, in patients with advanced solid tumors harboring KRAS alterations; preclinically, ABSK211 demonstrated broad-spectrum potent inhibition across G12D/G12C/G12S/G12V/G13D and wild-type amplification subtypes, with combination potential with PRMT5 inhibitors, cetuximab, immunotherapy and chemotherapy; it has received IND approvals from China's NMPA and the US FDA, with global clinical development advancing.
NewTimeSpace (newtimespace.com) News,August 31, 2026, ETHK LABS INC.(01931.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1.35 billion, increased by 6.63% YoY
NewTimeSpace (newtimespace.com) News,August 30, 2026, LIAONING PORT(02880.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 5.35 billion, decreased by 6.03% YoY
NewTimeSpace (newtimespace.com) News, August 28, 2026, ZGC TEC LEASING(01601.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 386.69 million, decreased by 7.37% YoY
NewTimeSpace (newtimespace.com) News, August 30, 2026, PETROCHINA(00857.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 1527.49 billion, increased by 5.34% YoY
NewTimeSpace (newtimespace.com) News,August 31, 2026, CHINA RES MIXC(01209.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 9.22 billion, increased by 8.13% YoY
NewTimeSpace News: On 31 August 2026, SBP GROUP (01177.HK) announced that the final Phase I data of Kylo-11 (LPA siRNA), a Class 1 innovative drug developed by its wholly-owned subsidiary Hejiya Biomedical, were presented at ESC 2026 as an LBCT oral presentation and published in full in The Lancet; among 70 subjects, a single dose significantly and durably reduced Lp(a), with mid-to-high dose groups achieving reductions of 94.6%-97.0% at week 48, approaching maximum reduction within about 4 weeks in the 225 mg and above groups and maintained through week 48, supporting the "once-a-year" dosing strategy; no serious adverse events occurred and tolerability was generally good; a Phase II study is underway in China and the US.
NewTimeSpace News: On 31 August 2026, HUTCHMED (00013.HK) announced that the SANOVO Phase III study in China of ORPATHYS plus TAGRISSO in treatment-naive EGFR-mutant NSCLC with MET overexpression met its primary endpoint, demonstrating a statistically significant and highly clinically meaningful PFS improvement in both the high-MET and ITT populations, with encouraging OS benefit; the study enrolled 326 patients (NCT05009836), with a safety profile consistent with known profiles; the combination is already approved in China for previously treated patients based on SACHI, and the SAFFRON global Phase III also reported positive data in August 2026.
NewTimeSpace News: On 31 August 2026, RIVERINE CHINA (01417.HK) announced that the Board has resolved, while continuing to develop its existing property management/building leasing/catering/sanitation businesses, to establish a new AI infrastructure business and gradually build an AI Token Economy system centered on AI Token production and distribution; the Group has established TokenVerse Holdings Limited (intermediate holding company) and the domestic entity Shanghai Ciyuan Wanxiang Information Technology Co., Ltd.; the announcement clarified that AI Token is only a service measurement unit, not any currency or virtual asset, and the AI Token Economy does not involve the issuance of virtual currency or digital assets.
This week, Hong Kong sub-new-listings ended mixed, with HIPINE up 30.55% to lead gains, while B&K CORP-B, after surging 68% last week, retreated 25.55%. JIAXIN INTL RES fell 4.87% for the week after unlocking 280 million shares, and SHUANGDENG fell 7.36%, with the impact mild. DEEPZERO's cumulative gain of 1,320% overtook QIYUNSHAN FOOD to top the list, while CIDI's discount widened to 93.12%. Z.AI's average daily turnover fell to HKD 4.672 billion, the lowest since July. Next week, AUX ELECTRIC will unlock 1.301 billion shares, a notably large size.
NewTimeSpace News: The HSI fell 1.63% this week, the Hang Seng TECH Index fell 3.38% and the Hang Seng China Enterprises Index fell 1.67%, with southbound capital posting a net inflow of approximately HKD 15.8 billion for the week. Alibaba announced an HKD 80 billion placement with 100% of proceeds directed to AI infrastructure, and its shares fell about 7.5% for the week, while Jack Ma and management made combined purchases exceeding HKD 800 million. The HSI quarterly review continued to resonate, with 54 stocks expected to enter Stock Connect on 7 September and an estimated HKD 38.6 billion of flows; DIAGENS-B and STAR SPORTS MED led gains, and ZJ INNOLIGHT was officially added to Stock Connect. The CRO/innovative drug complex was strong first and weak later, with EVEREST MED up over 18% on Tuesday; TIANQI LITHIUM's interim net profit surged 49 times. SHEIN-W completed its offering for a 1 September listing, and Medcaptain Medical Technology launched its offering.
NewTimeSpace News: On 28 August 2026 (after trading hours), CHINA BAOLI TEC (00164.HK) announced that it has entered into subscription agreements with 20 subscribers to allot 132,682,600 new shares at HKD 0.481 per share (representing about 38.00% of existing issued shares), for gross proceeds of approximately HKD 63.82 million and net proceeds of approximately HKD 60.3 million; the proceeds are intended for working capital, the converged media business and the dry-grinding and dry-separation business of the Mongolian mining project; the subscription requires shareholders' approval of a specific mandate at the EGM, with 11 subscribers holding existing interests required to abstain from voting.
NewTimeSpace News: On 30 August 2026, ZCZL (00564.HK) announced that it has obtained a share buyback special loan commitment letter from the Zhengzhou Branch of China CITIC Bank, with a committed amount of no more than RMB 360.00 million and a term of no more than 36 months for the exclusive purpose of repurchasing A shares; the Company's repurchase plan involves total funds of RMB 300-400 million (part for cancellation and part for equity incentives/employee shareholding plans), approved by the Board and shareholders' meetings, with specific terms subject to the loan contract and repurchase implementation results.
